BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,835.00
-5.00 (-0.10%)
At close: Aug 21, 2026

BioNote Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
56,61017,871107,341147,395681,067418,612
Short-Term Investments
295,292307,098298,076252,773672.4470,000
Trading Asset Securities
16,37314,844--39,722-
Cash & Short-Term Investments
368,274339,813405,416400,168721,461488,612
Cash Growth
4.35%-16.18%1.31%-44.53%47.65%139.97%
Accounts Receivable
27,65631,46022,00618,17416,37483,961
Other Receivables
5,8905,0573,0796,6901,930117.81
Receivables
33,54636,51725,08524,86418,30484,079
Inventory
31,40827,69325,02930,68379,03864,859
Prepaid Expenses
2,6691,366366.89500.11,76351.86
Other Current Assets
1,3131,4349,804261.774,2693,107
Total Current Assets
437,210406,824465,700456,478824,836640,709
Property, Plant & Equipment
84,14684,81092,63589,59497,15998,007
Long-Term Investments
1,087,1181,058,3281,132,2681,035,075827,748743,863
Goodwill
677.68677.68677.685,5125,5125,512
Other Intangible Assets
2,1222,6433,6384,7501,589354.16
Other Long-Term Assets
834.64539.55854.79491.43157.1422.15
Total Assets
1,614,1611,555,8921,697,1571,592,8421,757,0021,488,867

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,2504,1612,5413,5203,3025,412
Accrued Expenses
2,1521,7361,9791,5914,6899,547
Current Portion of Leases
1,4371,4931,3931,334468.57295.95
Current Income Taxes Payable
10,4471,32214,207467.5635,15795,913
Other Current Liabilities
4,3034,4063,5363,8885,8897,105
Total Current Liabilities
23,58913,11923,65610,80149,505118,273
Long-Term Leases
1,7742,1582,5383,594893.3473.7
Long-Term Deferred Tax Liabilities
37,66528,93634,81721,652106,30097,517
Other Long-Term Liabilities
477.26432.7374.06219.19151.1199.29
Total Liabilities
63,50544,64561,38436,266156,850216,363

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
51,26851,02851,02851,02850,93846,778
Additional Paid-In Capital
64,39759,74482,74482,74480,99711,877
Retained Earnings
1,366,9451,342,8201,427,6161,392,8281,466,0341,207,900
Treasury Stock
-4,867-8,109-3,108---
Comprehensive Income & Other
72,91365,76477,49329,9762,1835,948
Shareholders' Equity
1,550,6561,511,2471,635,7731,556,5761,600,1521,272,504
Total Liabilities & Equity
1,614,1611,555,8921,697,1571,592,8421,757,0021,488,867

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3,2113,6513,9314,9281,362769.65
Net Cash (Debt)
365,063336,162401,485395,240720,100487,842
Net Cash Growth
4.58%-16.27%1.58%-45.11%47.61%140.00%
Net Cash Per Share
3620.583321.223937.743875.767637.275206.96
Filing Date Shares Outstanding
100.8100.43101.36102.06101.8893.56
Total Common Shares Outstanding
100.8100.43101.36102.06101.8893.56
Working Capital
413,621393,705442,045445,677775,331522,435
Book Value Per Share
15383.1815047.1116137.7515252.1715706.8513601.52
Tangible Book Value
1,547,8571,507,9261,631,4571,546,3131,593,0511,266,638
Tangible Book Value Per Share
15355.4115014.0516095.1715151.6115637.1513538.81
Land
38,35938,35938,35938,35914,54114,541
Buildings
22,53228,67128,41228,00225,23325,905
Machinery
15,48637,76032,48131,12238,87330,865
Construction In Progress
334.422938,9802,00227,82135,303